Biotussin DAC and Insulin glargine and lixisenatide Subcutaneous
Determining the interaction of Biotussin DAC and Insulin glargine and lixisenatide Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: codeine / guaifenesin / pseudoephedrine
Brand name: Ambifed CD, Biotussin DAC, Cheratussin DAC, Guaifen DAC, Lortuss EX, Maxifed-G CD, Nucofed Pediatric Expectorant, Tricode GF, Tusnel C, Virtussin DAC, Virtussin DAC
Synonyms: n.a.
Generic Name: insulin glargine / lixisenatide
Brand name: Soliqua 100/33
Synonyms: Insulin glargine and lixisenatide (Subcutaneous)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Biotussin DAC-Insulin glargine, recombinant Subcutaneous
- Biotussin DAC-Insulin glulisine
- Biotussin DAC-Insulin Glulisine (Cartridges and Pens)
- Biotussin DAC-Insulin Glulisine (Vials)
- Biotussin DAC-Insulin glulisine Subcutaneous
- Biotussin DAC-Insulin human inhaled Inhalation
- Insulin glargine and lixisenatide Subcutaneous-Biperiden
- Insulin glargine and lixisenatide Subcutaneous-Biperiden Hydrochloride
- Insulin glargine and lixisenatide Subcutaneous-Bisa-Lax
- Insulin glargine and lixisenatide Subcutaneous-Bisacodyl
- Insulin glargine and lixisenatide Subcutaneous-Bisacodyl and polyethylene glycol (PEG) 3350 with electrolytes
- Insulin glargine and lixisenatide Subcutaneous-Bisacodyl Enema